Serum response factor (SRF) is an identified target for miR-122 in HCC cells [6], and SRF interacts with myocardin-related transcription factor to drive transcription of α-SMA and COL1A1 [2, 13, 14]. The gene discussed is MYOCD; the disease is hepatocellular carcinoma.